HIV medicine 2007
- 818 p. : ill. ; 23 cm.
- Schriftenreihe des Zentrums für Europäische Rechtspolitik an der Universität Bremen, ZERP ; Bd. 58 .
- Schriftenreihe des Zentrums für Europäische Rechtspolitik an der Universität Bremen, ZERP ; Bd. 58 .
"This volume makes two things available to the public: the editor's legal expert opinion commissioned by the German Ministry of Health in early 2008 ... and the proceedings of a conference organised to discuss the opinion's findings in Bremen on 9-10 October 2008"--P. 9.
Includes bibliographical references.
General political and economic conditions affecting access to life-saving medicines in the enlarged European Union / Ortwin Schulte -- Differential pricing of patent-protected pharmaceuticals for life-threatening infectious-diseases inside Europe : can compulsory licenses be employed? / Christine Godt -- Community exhaustion : does European law allow for flexibility? / Werner Schroeder -- European competition law, community-wide exhaustion and compulsory licenses : disintegrating the internal market in the public interest / Hans Ullrich -- Differential pricing : piercing of fostering the IP incentive for public health? / Geertui van Overwalle -- Price differentiation and the conundrum of exhausting principles / Heinz Goddar -- Lessons to be learned in Europe from the international discourse on patents and public health / Jerome H. Reichman -- Differential pricing of pharmaceuticals : lessons from economic theory / Sabine Richard -- Pharmaceutical pricing policy in a global market : cross-border impact on the availability and prices / Valérie Paris -- Protection and regulation of pharmaceutical in Bulgaria / Nadia Ianeva -- Intellectual property rights and access to HIV medicines in Estonia / Aleksei Kelli -- Research incentives from a public health perspective : the role of public funded research / Christian Wagner-Ahlfs.
3-924774-59-5 3-924774-59-5
2010455973
Drugs--Law and legislation--European Union countries. Drugs--Prices--European Union countries. Drugs--Patents. Compulsory licensing of patents--European Union countries. Pharmaceutical industry--European Union countries.